Articles
Export record to excel
File type to download
Record title
Second-line dovitinib (TKI258) in patients with FGFR2 -mutated or FGFR2 -non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
Record identifier
TN_cdi_proquest_journals_1683584578
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1683584578
Share
Second-line dovitinib (TKI258) in patients with FGFR2 -mutated or FGFR2 -non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
- Online access available on login with a Library card.
Second-line dovitinib (TKI258) in patients with FGFR2 -mutated or FGFR2 -non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Record Identifier
Language
English
Formats
Publication information
Publisher
Subjects
More information
— SCOPE AND CONTENTS
Contents
— ALTERNATIVE TITLES
Full title
— AUTHORS, ARTISTS AND CONTRIBUTORS
Identifiers
— PRIMARY IDENTIFIERS
Record Identifier
TN_cdi_proquest_journals_1683584578
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1683584578